P46352 9th Annual Biosimilars Asia 2018
Download Brochure Request

Register your interest


Register your interest


9th Annual Biosimilars Asia 2018

15 – 17 May 2018, Hilton Shanghai Hongqiao Hotel, China

Register Your Interest Download Brochure



The global biosimilars market is expected to reach $35 billion by 2030. Their uptake though faces considerable challenges in context to regulatory uncertainty, production complexity, interchangeability and competition. At IBC Asia’s 9th Annual Biosimilars Asia, top industry players will come together to explore tactics for overcoming hurdles unique to biosimilars in China, and globally. A focus on partnerships and commercial opportunities will be complemented by insights on disruptive technologies in manufacturing, commercialisation, risk management and pharma co-vigilance.

2018 Attendees List

View list >>

Key Highlights

  • 300+ Companies, 70+ speakers, 60+ Sessions
  • Unparalleled learning and targeted networking across three (3) co-located events
  • Assess global potential in the biosimilars market
  • Review the attractiveness of China as a continued investment destination
  • Developments in regulatory pathways and approvals in China
  • Examine advances in Innovation & Technology for Biosimilar Development
  • Optimise development strategies and production capabilities to ensure high product quality and stay ahead of competition
  • Preview latest equipment and technologies and hear from top vendors on how they are partnering with your peers

Choose your language

Part of

Biopharma Development & Production >>

Co-Located Events

Biosimilars Asia >>
Cell Line Development and Engineering >>
Biomanufacturing >>


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

VIP Programme

Become a VIP!
IBC Asia’s VIP Programme is an invitation only based network of the absolute top decision makers across specific industries. Our VIPs get an exclusively designed and tailored programme that enables them to network, indulge and enjoy, whilst experiencing a premium service for the duration of this event.

Dedicated to helping you find the most effective way of engaging with professionals and industry solution providers at our event, and scheduled alongside the main event line-up, it gives you an opportunity to glean benefits from the conference as well, and ensures that you get the most of your time on site with us.

Benefits of becoming a VIP:

  • 1-2-1 Meeting Service (Pre-scheduling meetings with your peers, speakers and other participants you may want to meet)
  • Closed Door Think Tank (An invitation-only forum headlined by an exclusive keynote address)
  • The VIP Lounge
  • Opening Ceremony (Access priority seats and be the first to engage with key speakers and other top decision makers)
  • Your Interview, Promoted Exclusively

A personalized VIP agenda will be sent to you via email upon receiving the confirmation of your registration.

To find out more, please contact:
Angeline Tan, VIP Relations Manager
Email: Angeline.Tan.SG1@ibcasia.com.sg
Phone: +65 6508 2874

Download VIP Programme brochure »


Dr. Ming Wang

President and Chief Executive Officer, Phanes Biopharmaceuticals, China

Xiao Zhi Hua

Chief Executive Officer, OPM Biosciences, China

Xu Wei

Vice President, Manufacturing, Innovent Biologics, China

Jerry Yang

SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Dr Jun Liu

Vice President, TOT Biopharma, China

Yanshan Huang

Chief Executive Officer, DOER Biologics, China

Andrew Huntley

Senior Managing Director, BDA Partners, UK

Dr. Ryan Karcher

Senior R&D Scientist & Team Lead, Merck, USA

Henry Zhang

APAC Technical Application Representative – Cell Nutrition, Kerry Inc., China

Dr. Scott Liu

President and CEO, Shanghai Henlius Biotech Inc., China

Dr. Manfred Weiler

Senior Vice President, Medical & Scientific Strategy, Syneos Health, UK

Dr. Jacqueline Ming Liu

Vice President, TOT Biopharma, China

Dr Qiwei Wu

Ph.D, Vice President of Process Development and Manufacturing, Livzon Mabpharma

Dr Amy Hong Que

Vice President - Quality, Innovent Biologics

Dr. Alvin Luk

Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Prof. Dr. Florian Turk

Head Global Payor Marketing, Sales and Relations, Sandoz Biopharmaceuticals Sandoz International GmbH, Germany

Pearl Fong

Associate Vice President, Division of Project Development, Mycenax Biotech Inc., Taiwan

Bryan Kim

Vice President of Business Development, Samsung Bioepis, Korea

Dr. Sven Bahrke

Senior Director Cooperations, Glycotope GmBH

Dr. Xin Zhang

Vice President of Global Clinical Operations and Affairs, Shanghai Henlius Biotech, Inc., China

MinSeob Lee

Team Leader of R&D CMC/PM, Celltrion R&D, Korea

Eric Liu

China Biosimilars Regulation Publishing Manager, Pfizer, China

Jiang Junjun

Assistant Director, WuXi Biologics, China

Yun Kang

Vice President of Manufacturing, Generon Beijing, China

Zheru Zhang

President, I-Mab Biopharma, China

Shaoqing Yang

Vice President, Zhejiang Doer Biologics Co.

Yunfen He

Senior Director, OPM Biosciences

Zhigui Zhou

Director, OPM Biosciences

Lihou Dong

Senior Director, United-Power Pharma

when & where

15 - 17 May 2018

Hilton Shanghai Hongqiao
No. 1116 Hong Song East Rd, Shanghai, 201103, China
Tel: +86-21-3323 6666


Still have a question?

Speaking Opportunities
Sheralin See
+65-6508 2442

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
June Tan
+65 6508 2465


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more